{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_notes_note in Note (approximate match)
Status:
Investigational
Source:
NCT03255070: Phase 1 Interventional Completed Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:golocdacimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03595059: Phase 1 Interventional Active, not recruiting Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02877134: Phase 2 Interventional Completed Crohn Disease
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04541186: Phase 2 Interventional Completed Severe Hypertriglyceridemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01678417: Phase 2 Interventional Unknown status Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:briquilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efocipegtrutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04297995: Phase 2 Interventional Active, not recruiting Head and Neck Squamous Cell Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pivekimab sunirine [INN]
Source URL:
Class:
PROTEIN
